Evidence map›Paper›PMID 38392528›Full record

ArticleInsects2024

Anti-Herpes Simplex Virus and Anti-Inflammatory Activities of the Melittin Peptides Derived from

Pichet Praphawilai, Thida Kaewkod, Sureeporn Suriyaprom, Aussara Panya, Terd Disayathanoowat, Yingmanee Tragoolpua

Open access · goldAbstract read
In one paragraph

Article in Insects, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. A Comparative Study of Melittins fromInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Therapeutic Potential ofBiomolecules · 2024
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pichet PraphawilaiDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0009-0008-6387-9231
Thida KaewkodDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Sureeporn SuriyapromDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Aussara PanyaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
Terd DisayathanoowatDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-6416-2266
Yingmanee TragoolpuaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0754-0638
Chiang Mai University · TH

Funding

Thailand Science Research and Innovation MSD61I0025
6 · The paper itself

Abstract

Herpes simplex virus (HSV) is known to cause cold sores and various diseases in humans. Importantly, HSV infection can develop latent and recurrent infections, and it is also known to cause inflammation. These infections are difficult to control, and effective treatment of the disease remains a challenge. Thus, the search for new antiviral and anti-inflammatory agents is a necessity. Melittin is a major peptide that is present in the venom of the honeybee. It possesses a number of pharmacological properties. In this study, the effects of the melittin peptides from

Indexed as

anti-herpes simplex virusanti-inflammationbee venomherpes simplex virusmelittinplaque reduction assayvirucidal assay

Identifiers

PMID38392528
PMCPMC10888738
OpenAlexW4391535578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.